Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression
暂无分享,去创建一个
A. Wells | P. Doherty | D. Reeves | A. Heagerty | G. Shields | Lora Capobianco | D. Buck | L. Davies
[1] P. Bower,et al. Training to enhance user and carer involvement in mental health-care planning: the EQUIP research programme including a cluster RCT , 2019, Programme Grants for Applied Research.
[2] Sally J. Singh,et al. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis , 2019, European journal of preventive cardiology.
[3] A. Mandrusiak,et al. Cost-Utility Analysis of Home-based Telerehabilitation Compared with Centre-based Rehabilitation in Patients with Heart Failure. , 2019, Heart, lung & circulation.
[4] N. Morina,et al. The Efficacy of Metacognitive Therapy: A Systematic Review and Meta-Analysis , 2018, Front. Psychol..
[5] C. Clements,et al. Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care – the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and Suicidality) programme , 2018, Programme Grants for Applied Research.
[6] C. Jackson,et al. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial , 2018, The lancet. Psychiatry.
[7] A. Wells,et al. Cost-effectiveness of cardiac rehabilitation: a systematic review , 2018, Heart.
[8] A. Wells,et al. Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial , 2018, Trials.
[9] James R Carpenter,et al. Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey , 2018, Health economics.
[10] J. Refsgaard,et al. Shared care versus hospital-based cardiac rehabilitation: a cost-utility analysis based on a randomised controlled trial , 2018, Open Heart.
[11] Graham Meadows,et al. Simulation modelling in mental health: A systematic review , 2018, J. Simulation.
[12] Brendan Mulhern,et al. Valuing health‐related quality of life: An EQ‐5D‐5L value set for England , 2017, Health economics.
[13] A. Abu-Hanna,et al. Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study , 2017, European journal of preventive cardiology.
[14] H. Riper,et al. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review , 2017, PharmacoEconomics - Open.
[15] P. Doherty,et al. Cost–utility analysis of cardiac rehabilitation after conventional heart valve surgery versus usual care , 2017, European journal of preventive cardiology.
[16] P. Bower,et al. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial , 2016, BMJ Open.
[17] Karl Claxton,et al. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal. , 2016, Health economics.
[18] J. Holroyd-Leduc,et al. Measuring Resource Utilization , 2016, Medicine.
[19] J. Kai,et al. A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial. , 2015, Health technology assessment.
[20] P. Doherty,et al. Cardiac rehabilitation , 2015, BMJ : British Medical Journal.
[21] Karl Claxton,et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. , 2015, Health technology assessment.
[22] Manuel Gomes,et al. A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials , 2014, PharmacoEconomics.
[23] A. F. Stern. The hospital anxiety and depression scale. , 2014, Occupational medicine.
[24] N. Morina,et al. THE EFFICACY OF METACOGNITIVE THERAPY FOR ANXIETY AND DEPRESSION: A META‐ANALYTIC REVIEW , 2014, Depression and anxiety.
[25] Jon Sussex,et al. Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold , 2013 .
[26] M. Drummond,et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. , 2013, BMJ.
[27] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[28] T. Kohlmann,et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[29] Anthony J. Culyer,et al. The NICE Cost-Effectiveness Threshold , 2012, PharmacoEconomics.
[30] Casper J. P. Zhang,et al. INTERIM SCORING FOR THE EQ-5 D-5 L : MAPPING THE EQ-5 D-5 L TO EQ-5 D-3 L VALUE SETS Methodology , 2011 .
[31] Adrian Wells,et al. Metacognitive Therapy for Anxiety and Depression , 2008 .
[32] H. Cox,et al. A brief cognitive behavioural preimplantation and rehabilitation programme for patients receiving an implantable cardioverter-defibrillator improves physical health and reduces psychological morbidity and unplanned readmissions , 2007, Heart.
[33] A J Mourant,et al. Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost effectiveness analysis. , 2007, International journal of cardiology.
[34] Ian R White,et al. Adjusting for partially missing baseline measurements in randomized trials , 2005, Statistics in medicine.
[35] H. Hahmann,et al. Validation of the EuroQol questionnaire in cardiac rehabilitation , 2005, Heart.
[36] D. Stewart,et al. Cardiac rehabilitation II: referral and participation. , 2002, General hospital psychiatry.
[37] Edward R. Watkins,et al. Attention and emotion: A clinical perspective , 1997 .
[38] A. Wells,et al. Modelling cognition in emotional disorder: the S-REF model. , 1996, Behaviour research and therapy.
[39] A. Wells,et al. Attention and Emotion: A Clinical Perspective , 1994 .
[40] R. Snaith,et al. The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.